M&T Bank Corp Buys 29,546 Shares of Cognex Corporation $CGNX

M&T Bank Corp lifted its stake in Cognex Corporation (NASDAQ:CGNX) by 58.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 80,511 shares of the scientific and technical instruments company’s stock after acquiring an additional 29,546 shares during the period. M&T Bank Corp’s holdings in Cognex were worth $2,897,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in CGNX. AQR Capital Management LLC raised its stake in shares of Cognex by 18,810.9% in the 2nd quarter. AQR Capital Management LLC now owns 1,794,649 shares of the scientific and technical instruments company’s stock valued at $56,657,000 after acquiring an additional 1,785,159 shares in the last quarter. Pictet Asset Management Holding SA raised its stake in shares of Cognex by 27.9% in the 4th quarter. Pictet Asset Management Holding SA now owns 7,013,184 shares of the scientific and technical instruments company’s stock valued at $252,360,000 after acquiring an additional 1,529,010 shares in the last quarter. Nordea Investment Management AB raised its stake in shares of Cognex by 13.4% in the 3rd quarter. Nordea Investment Management AB now owns 8,025,371 shares of the scientific and technical instruments company’s stock valued at $361,382,000 after acquiring an additional 949,599 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Cognex by 43.9% in the 3rd quarter. Bank of New York Mellon Corp now owns 3,024,355 shares of the scientific and technical instruments company’s stock valued at $137,003,000 after acquiring an additional 922,149 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its stake in shares of Cognex by 10,861.7% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 782,776 shares of the scientific and technical instruments company’s stock valued at $35,460,000 after acquiring an additional 775,635 shares in the last quarter. 88.12% of the stock is owned by institutional investors.

Key Cognex News

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Cognex reported a strong Q1: revenue ~$268M (+~24% y/y), adjusted EPS $0.34 (beat), material margin expansion (gross margin and adjusted EBITDA margin materially higher), and operating leverage that boosted profitability — the core driver of the rally. Cognex shares jump on Q1 beat and upbeat Q2 outlook
• Positive Sentiment: Management provided upbeat Q2 guidance: revenue $280–$300M and adjusted EPS $0.40–$0.44, above consensus, implying continued sequential momentum and supporting re-rating. Cognex Reports First Quarter 2026 Results
• Positive Sentiment: The board declared a quarterly dividend ($0.085), a small signal of confidence in free cash flow and capital return to shareholders. Cognex shares jump on Q1 beat and upbeat Q2 outlook
• Positive Sentiment: Unusually large call buying (≈9,163 calls, ~652% above normal) indicates speculative or institutional bullish positioning that can amplify intraday upside. (Market options flow reported). Earnings Call Transcript / Flow
• Positive Sentiment: Stephens raised its price target to $75 and moved to “overweight,” giving the stock additional analyst momentum and validation of the better outlook. Benzinga
• Neutral Sentiment: Public filings and the full earnings transcript/slide deck were released (useful for due diligence but not incremental news). Q1 2026 Earnings Call Transcript
• Neutral Sentiment: Multiple outlets (Zacks, Yahoo, Kalkine) reported the beat and guidance — broad media coverage can support liquidity and attention but is secondary to the results. Zacks: Q1 Earnings and Revenues Top Estimates
• Negative Sentiment: Significant insider selling has occurred in recent months (multiple executive sales), which some investors view as a cautionary signal on timing despite the company’s strong results. Insider Trading Details
• Negative Sentiment: Large institutional moves include a notable reduction by a major holder (Northwestern Mutual), which could increase supply pressure or reflect portfolio rebalancing. Monitor 13F/ownership updates for follow-through. Institutional Activity

Cognex Stock Up 6.2%

CGNX opened at $66.13 on Friday. The firm has a market capitalization of $11.04 billion, a P/E ratio of 78.72 and a beta of 1.48. The stock’s 50 day moving average price is $52.67 and its two-hundred day moving average price is $45.20. Cognex Corporation has a 12-month low of $28.56 and a 12-month high of $71.90.

Cognex (NASDAQ:CGNX) last released its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.09. Cognex had a return on equity of 10.86% and a net margin of 13.62%.The firm had revenue of $268.44 million for the quarter, compared to analyst estimates of $245.98 million. During the same quarter last year, the firm posted $0.14 EPS. The company’s revenue was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. As a group, analysts anticipate that Cognex Corporation will post 0.97 earnings per share for the current year.

Cognex Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st will be given a $0.085 dividend. The ex-dividend date is Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. Cognex’s dividend payout ratio (DPR) is currently 50.75%.

Insiders Place Their Bets

In other Cognex news, VP Laura Ann Macdonald sold 14,881 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $57.16, for a total value of $850,597.96. Following the completion of the sale, the vice president owned 2,212 shares in the company, valued at approximately $126,437.92. This trade represents a 87.06% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert Willett sold 177,052 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $58.39, for a total value of $10,338,066.28. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 196,083 shares of company stock worth $11,419,321. 1.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

CGNX has been the topic of a number of research analyst reports. Needham & Company LLC raised their target price on Cognex from $47.00 to $67.00 and gave the company a “buy” rating in a report on Thursday, February 12th. KeyCorp reaffirmed an “overweight” rating and issued a $70.00 target price (up from $50.00) on shares of Cognex in a report on Friday, February 13th. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Cognex in a report on Thursday, February 12th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $75.00 target price on shares of Cognex in a report on Thursday. Finally, DA Davidson set a $55.00 target price on Cognex and gave the company a “neutral” rating in a report on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $61.71.

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.